Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis
Mohd Rihan, Shyam Sunder Sharma
Topics & Concepts
PKM2MedicineMyocardial infarctionPharmacologyMyocardial fibrosisReperfusion injuryApoptosisFibrosisInflammationPyruvate kinaseInternal medicineIschemiaChemistryGlycolysisBiochemistryMetabolismChemotherapy-induced cardiotoxicity and mitigationNitric Oxide and Endothelin EffectsBioactive Compounds and Antitumor Agents